Evome Medical Technologies Inc. (TSXV:EVMT)

Canada flag Canada · Delayed Price · Currency is CAD
0.0050
0.00 (0.00%)
May 29, 2026, 9:30 AM EST
Market Cap415.00K -97.5%
Revenue (ttm)48.34M -16.3%
Net Income-23.53M
EPS-0.27
Shares Out 83.00M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Open0.0050
Previous Close0.0050
Day's Range0.0050 - 0.0050
52-Week Range0.0050 - 0.2150
Beta2.22
Analystsn/a
Price Targetn/a
Earnings DateJun 1, 2026

About TSXV:EVMT

Evome Medical Technologies Inc. designs, develops, produces, and sells medical devices in the United States. The company was formerly known as Salona Global Medical Device Corporation and changed its name to Evome Medical Technologies Inc. in January 2024. The company is based in Shirley, New York. [Read more]

Sector Healthcare
CEO Christopher Heath
Employees 205
Stock Exchange TSX Venture Exchange
Ticker Symbol EVMT
Full Company Profile

Financial Performance

In 2023, TSXV:EVMT's revenue was 62.63 million, an increase of 55.35% compared to the previous year's 40.31 million. Losses were -15.60 million, -18.21% less than in 2022.

Financial Statements

News

Michael Dalsin Resigns as Chairman of the Board of Directors of Evome Medical Technologies

NEW YORK, April 09, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (“Evome”, the “Company”) (TSXV: EVMT) ‎announced the resignation of Michael Dalsin as Chairman of the Board of Directors. M...

1 year ago - GlobeNewsWire

Evome Medical Technologies Provides Market Update

NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) is providing an update to shareholders today.

1 year ago - GlobeNewsWire

Evome Medical Technologies Appoints Michael Dalsin as Chairman of the Board of Directors; Increases Size of Board to Six

NEW YORK, March 17, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company”) (TSXV: EVMT) ‎announces the appointment of Michael Dalsin as Chairman of the Board of Directors. Kenneth Ka...

1 year ago - GlobeNewsWire

CLARIFICATION: Evome Medical Technologies Announces Significant Debt Restructuring

SHIRLEY, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company”) (TSXV: EVMT) issued a press release on Monday, February 10, 2025 announcing the details of an amendment...

1 year ago - GlobeNewsWire

Evome Medical Technologies Announces Significant Debt Reduction and Restructuring

SHIRLEY, N.Y., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company”) (TSXV: EVMT) has announced a significant reduction in its overall ‎debt, strengthening its financial po...

1 year ago - GlobeNewsWire

Evome Medical Technologies Grants Restricted Stock Units to New Chief Operating Officer

SHIRLEY, N.Y., Jan. 20, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company”) (TSXV: EVMT) is pleased to announce that the Company's Board of Directors has approved the grant of 1,0...

1 year ago - GlobeNewsWire

Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt

Launches Evome Medical Products Distribution Company, Appoints Bill Garbarini Chief Operating Officer Adding Plan for a broader portfolio of Life Science Products Launches Evome Medical Products Distr...

1 year ago - GlobeNewsWire

Evome Medical Technologies Earnings release: Q3 2024

Evome Medical Technologies released its Q3 2024 earnings on November 25, 2024, summarizing the period's financial results.

1 year ago - Filings

Evome Medical Technologies Registration statement: Q3 2024

Evome Medical Technologies filed a registration statement on November 25, 2024, providing details about a securities offering with the SEC.

1 year ago - Filings

Evome Medical Technologies Registration statement: Q3 2024

Evome Medical Technologies filed a registration statement on November 25, 2024, providing details about a securities offering with the SEC.

1 year ago - Filings

Evome Medical Technologies Announces Results From Its Annual General and Special Meeting of Shareholders

SHIRLEY, N.Y., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today announced ‎the results from its annual general and special meeting of sha...

1 year ago - GlobeNewsWire

Evome Medical Technologies Earnings Call Transcript: Q2 2024

Q2 2024 saw strong revenue and profit growth in the core business, with positive adjusted EBITDA and significant debt reduction. Asset sales and a new white-labeling strategy are set to further improve financial health and drive growth in 2025.

1 year ago - Transcripts

Evome Medical Technologies Earnings release: Q2 2024

Evome Medical Technologies released its Q2 2024 earnings on August 19, 2024, summarizing the period's financial results.

1 year ago - Filings

Evome Medical Technologies Registration statement: Q2 2024

Evome Medical Technologies filed a registration statement on August 19, 2024, providing details about a securities offering with the SEC.

1 year ago - Filings

Evome Medical Technologies Registration statement: Q2 2024

Evome Medical Technologies filed a registration statement on August 19, 2024, providing details about a securities offering with the SEC.

1 year ago - Filings

Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan

Posts updated corporate presentation to website Reminder: Conference call to be held on August 19 th to discuss Q2 2024 financial results SHIRLEY, N.Y., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Evome Medical...

1 year ago - GlobeNewsWire

Evome Medical Technologies Reports Second Quarter 2024 Financial Results

SHIRLEY, N.Y., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. ‎(the “Company” or “Evome”) (TSXV: EVMT) today reported financial results for the second quarter ended June 30, 2024, f...

1 year ago - GlobeNewsWire

Evome Medical Technologies Retains irlabs for Investor Relations Services

NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) is pleased to announce it has entered into an agreement ("Agreement") with IR Labs I...

2 years ago - GlobeNewsWire

Evome Medical Technologies Transcript: Guidance

Significant turnaround achieved with cost cuts, asset sales, and new product launches driving revenue growth. Plans include further debt reduction, expansion into private physical therapy, and continued innovation, with positive financial momentum expected.

2 years ago - Transcripts

Evome Medical Technologies Press release: Guidance

Evome Medical Technologies issued a press release on June 4, 2024, disclosing material business information to investors.

2 years ago - Filings

Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today provided details on preliminary estimated revenues and margins from April and ...

2 years ago - GlobeNewsWire

Evome Medical Technologies Announces Biodex Generated 100% Sales Growth Comparing April 2024 to January 2024, Plans to Shed Remaining Non-Core Units to Pay Off Remaining Acquisition Debt

NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today reported continued progress on its turn-around plan. Evome has grown revenue at...

2 years ago - GlobeNewsWire

Evome Medical Technologies Earnings release: Q1 2024

Evome Medical Technologies released its Q1 2024 earnings on May 30, 2024, summarizing the period's financial results.

2 years ago - Filings

Evome Medical Technologies Registration statement: Q1 2024

Evome Medical Technologies filed a registration statement on May 30, 2024, providing details about a securities offering with the SEC.

2 years ago - Filings

Evome Medical Technologies Registration statement: Q1 2024

Evome Medical Technologies filed a registration statement on May 30, 2024, providing details about a securities offering with the SEC.

2 years ago - Filings